LUCARA ANNOUNCES NON-BROKERED PRIVATE PLACEMENT BACKED BY THE LUNDIN FAMILY TRUSTS, TO ADVANCE UNDERGROUND PROJECT
LUCARA ANNOUNCES $10 MILLION DRAW FROM LIMITED SHAREHOLDER STANDBY UNDERTAKING AND RECENT NOTABLE DIAMOND RECOVERIES
Forbion Announces Second Exit from Forbion Growth Fund III Following $2.2 Billion Acquisition of RAPT Therapeutics by GSK